Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Voyager Technologies recently announced a new contract with Space LiinTech to manage a drug-discovery payload to the International Space Station, providing mission integration, payload configuration ...

Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.

Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...